Pharming Receives Japanese Patent on Recombinant Human Lactoferrin
10. August 2005 01:36 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, Aug. 10, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHAR.AS), a biotechnology company, announced today that it has been granted a...
Pharming Announces Research Collaboration With NovaThera
12. Juli 2005 01:12 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, July 12, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHARM.AS) announced today a research collaboration with NovaThera Limited...
Pharming to Receive Milestone Payment from Esteve
04. Juli 2005 02:07 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, July 4, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) announced today that it will receive a milestone payment from Laboratorios del Dr....
Pharming Announces Partnership With AgResearch For Human Lactoferrin
30. Juni 2005 01:05 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, June 30, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced today a partnership with AgResearch Limited ("AgResearch") on...
Pharming Announces Key Appointments To Strengthen Organization
24. Juni 2005 12:24 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, June 24, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) announced key appointments to further strengthen its organization in preparation...
Pharming Announces First Quarter 2005 Results
06. Mai 2005 01:41 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, May 6, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced today its first quarter (Q1) results for the period ended March...
Pharming Presents Phase II / III Clinical Results With Recombinant Human C1 Inhibitor
02. Mai 2005 01:38 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, May 2, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced today clinical results from Phase II/III clinical studies with...
Pharming Receives Over 800,000 Shares from Trust Foundation
29. April 2005 12:17 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, April 29, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced today that the Company is the beneficiary of over 800,000...
Pharming Announces Annual Shareholders Meeting
22. April 2005 02:06 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, April 22, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced that the Company's annual shareholders meeting (AGM) will be...
Pharming to Present at UBS Northern Europe Conference
11. April 2005 05:34 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, April 11, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHAR.AS) announced today that the Company will present at the UBS Northern...